Logo image of NXE

NEXGEN ENERGY LTD (NXE) Stock Fundamental Analysis

NYSE:NXE - New York Stock Exchange, Inc. - CA65340P1062 - Common Stock - Currency: USD

4.85  -0.08 (-1.62%)

After market: 4.98 +0.13 (+2.68%)

Fundamental Rating

2

Overall NXE gets a fundamental rating of 2 out of 10. We evaluated NXE against 210 industry peers in the Oil, Gas & Consumable Fuels industry. The financial health of NXE is average, but there are quite some concerns on its profitability. NXE does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

NXE had negative earnings in the past year.
NXE had a negative operating cash flow in the past year.
NXE had negative earnings in 4 of the past 5 years.
NXE had a negative operating cash flow in each of the past 5 years.
NXE Yearly Net Income VS EBIT VS OCF VS FCFNXE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M

1.2 Ratios

The Return On Assets of NXE (-4.68%) is worse than 80.48% of its industry peers.
NXE has a worse Return On Equity (-6.58%) than 75.71% of its industry peers.
Industry RankSector Rank
ROA -4.68%
ROE -6.58%
ROIC N/A
ROA(3y)-2.29%
ROA(5y)-11.88%
ROE(3y)-3.42%
ROE(5y)-30.84%
ROIC(3y)N/A
ROIC(5y)N/A
NXE Yearly ROA, ROE, ROICNXE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80 -100

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for NXE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NXE Yearly Profit, Operating, Gross MarginsNXE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

4

2. Health

2.1 Basic Checks

NXE has more shares outstanding than it did 1 year ago.
The number of shares outstanding for NXE has been increased compared to 5 years ago.
NXE has a worse debt/assets ratio than last year.
NXE Yearly Shares OutstandingNXE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
NXE Yearly Total Debt VS Total AssetsNXE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

NXE has an Altman-Z score of 4.62. This indicates that NXE is financially healthy and has little risk of bankruptcy at the moment.
NXE's Altman-Z score of 4.62 is amongst the best of the industry. NXE outperforms 90.00% of its industry peers.
NXE has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
NXE has a better Debt to Equity ratio (0.00) than 83.81% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 4.62
ROIC/WACCN/A
WACCN/A
NXE Yearly LT Debt VS Equity VS FCFNXE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

NXE has a Current Ratio of 1.03. This is a normal value and indicates that NXE is financially healthy and should not expect problems in meeting its short term obligations.
NXE has a Current ratio (1.03) which is in line with its industry peers.
NXE has a Quick Ratio of 1.03. This is a normal value and indicates that NXE is financially healthy and should not expect problems in meeting its short term obligations.
NXE's Quick ratio of 1.03 is in line compared to the rest of the industry. NXE outperforms 55.71% of its industry peers.
Industry RankSector Rank
Current Ratio 1.03
Quick Ratio 1.03
NXE Yearly Current Assets VS Current LiabilitesNXE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

2

3. Growth

3.1 Past

The earnings per share for NXE have decreased strongly by -268.95% in the last year.
EPS 1Y (TTM)-268.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-147.78%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

NXE is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -31.47% yearly.
NXE is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 242.04% yearly.
EPS Next Y-148.64%
EPS Next 2Y-67.25%
EPS Next 3Y-49.44%
EPS Next 5Y-31.47%
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y-25.99%
Revenue Next 5Y242.04%

3.3 Evolution

NXE Yearly Revenue VS EstimatesNXE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1B 2B 3B
NXE Yearly EPS VS EstimatesNXE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 0.2 -0.2 -0.4 -0.6

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NXE. In the last year negative earnings were reported.
Also next year NXE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NXE Price Earnings VS Forward Price EarningsNXE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NXE Per share dataNXE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

NXE's earnings are expected to decrease with -49.44% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-67.25%
EPS Next 3Y-49.44%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for NXE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NEXGEN ENERGY LTD

NYSE:NXE (3/7/2025, 8:04:00 PM)

After market: 4.98 +0.13 (+2.68%)

4.85

-0.08 (-1.62%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)03-04 2025-03-04/bmo
Earnings (Next)05-06 2025-05-06/bmo
Inst Owners52.62%
Inst Owner Change-1.18%
Ins Owners4.63%
Ins Owner ChangeN/A
Market Cap2.76B
Analysts81.11
Price Target10.01 (106.39%)
Short Float %11.19%
Short Ratio6.75
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.24%
PT rev (3m)-1.4%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)3.14%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 3.36
P/tB 3.36
EV/EBITDA N/A
EPS(TTM)-0.1
EYN/A
EPS(NY)-0.1
Fwd EYN/A
FCF(TTM)-0.19
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS0
BVpS1.45
TBVpS1.45
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.68%
ROE -6.58%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-2.29%
ROA(5y)-11.88%
ROE(3y)-3.42%
ROE(5y)-30.84%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 5802.98%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.03
Quick Ratio 1.03
Altman-Z 4.62
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)5324.66%
Cap/Depr(5y)3796.13%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-268.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-147.78%
EPS Next Y-148.64%
EPS Next 2Y-67.25%
EPS Next 3Y-49.44%
EPS Next 5Y-31.47%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y-25.99%
Revenue Next 5Y242.04%
EBIT growth 1Y42.54%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-0.9%
EBIT Next 3Y-4.84%
EBIT Next 5Y1.67%
FCF growth 1Y8.11%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y54.22%
OCF growth 3YN/A
OCF growth 5YN/A